IMA Q4 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$659,000-87.9% YoY

Gross Profit

$354,00053.7% margin

Operating Income

-$22M-3324.4% margin

Net Income

-$19M-2957.4% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-44.4%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$192M

Total Liabilities

$22M

Stockholders' Equity

$170M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$659,000	$5M	-87.9%
Gross Profit	$354,000	-$10M	+103.5%
Operating Income	-$22M	-$15M	-45.0%
Net Income	-$19M	-$14M	-38.2%